Silk Road Medical Inc (SILK) - Long-Term Debt to Capital Coefficient

The visual price representation of Silk Road Medical, Inc (SILK) available on the page demonstrates the price action of an asset whose strategy relies on cooperation with surgeons to implement ENROUTE protection systems. A flawless image as an innovator in minimally invasive therapy provides the company with immense credibility among physicians. The current indicator is 0.51, while US production facilities manufacture unique TCAR devices to combat strokes.

Professional selection of blue-chip assets requires rigorous filtering of debt loads. This metric compares liabilities with maturities exceeding one year against equity to assess financial stability. The strong pricing power of Silk Road Medical (SILK) in the TCAR segment allows the business to expand without excessive borrowing. The current long-term debt-to-equity ratio confirms a conservative approach to financing. A consistently low trend guarantees reliability but limits the leverage for returns.